Sun Pharmaceutical Industries Ltd Announces US FDA Approval for Generic Venlafaxine Extended Release Tablets

August 19, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI, India--(BUSINESS WIRE)--Sun Pharma announced that USFDA has granted an approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Venlafaxine Hydrochloride Extended Release tablets.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Asia

Food and Drug Administration (FDA)